Quality control of end results in a Danish adjuvant breast cancer multi- center study

Acta Oncologica

Volumn 36, Issue 7, 1997, Pages 711-714

  Hansen, Syrak ^a   Andersen, Erik ^a   Andersen, Knud West ^b   Mouridsen, Henning T ^b  

^a VIBORG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DENMARK; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 15644375173     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001342     Document Type: Article

References (11)

1. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). Ada Oncol 1988; 27: 627-47.
2. Dombernowsky P, Hansen PS, Mouridsen HT, Overgaard M, Rose C, Zedeler K. Randomized trial of adjuvant CMF + Radiotherapy vs CMF alone vs CMF + Tamoxifen in pre-and menopausal stage II breast cancer (Abstract). Eur J Cancer 1994; (Suppl 2) (30): 28.
3. Overgaard M, Hansen PS, Rose C, et al. Postmastectomy radiotherapy and adjuvant systemic treatment in high-risk cancer patients. (Abstract). Fur J Cancer 1994; (Suppl 2) (30): 28.
4. Rose C, Hansen PS, Dombernowsky P, et al. A randomized DBCG trial of adjuvant Tamoxifen + Radiotherapy vs. Tamoxifen alone vs. Tamoxifen + CMF in postmenopausal breast cancer patients with high risk recurrence. (Abstract). Eur J Cancer 1994; (Suppl 2) (30): 28.
5. Dombernowsky P, Brincker H, Hansen M, et al. Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials 77-B and 82-B. Ada Oncol 1988; 27: 691-7.
6. Overgaard M, Juul Christensen J, Johansen H, et al. Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials. Acta Oncol 1988; 27: 707-14.
7. Mouridsen HT, Rose C, Overgaard M, et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 1988; 27: 699-705.
8. Kamby C. The pattern of metastases in human breast cancer: Methodological aspects and influence of prognostic factors. Cancer Treatment Reviews 1990; 17: 37-61.
9. Zedeler K. Assessment and presentation of survival experience in the Danish Breast Cancer Cooperative Group. Acta Oncol 1988; 27: 649-62.
10. Vantongelen K, Steward W, Blackledge G, Verweij J, Van Oosterom A. Treatment-related variables and data acquisition in chemotherapy. Eur J Cancer 1991; 27: 201-7.
11. Vantongelen K, Rotmensz N, van der Schueren E. Quality control of validity of data collected in clinical trials. Eur J Cancer Clin Oncol 1989; 25: 1241-7.